Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LUCENTIS for Macular oedema: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 11 adverse event reports in the FDA FAERS database where LUCENTIS was used for Macular oedema.

Most Reported Side Effects for LUCENTIS

Side Effect Reports % Deaths Hosp.
Death 138 20.1% 138 2
Visual acuity reduced 98 14.3% 2 20
Vision blurred 64 9.3% 2 14
Cerebrovascular accident 54 7.9% 6 27
Off label use 54 7.9% 2 8
Eye pain 43 6.3% 1 3
Visual impairment 43 6.3% 4 10
Vitreous floaters 42 6.1% 2 11
Blindness 34 5.0% 1 1
Drug ineffective 33 4.8% 0 3
Myocardial infarction 33 4.8% 8 16
Cataract 27 3.9% 0 6
Macular oedema 26 3.8% 0 3
Retinal haemorrhage 26 3.8% 0 8
Cataract nuclear 20 2.9% 0 5

Other Indications for LUCENTIS

Age-related macular degeneration (248) Product used for unknown indication (191) Diabetic retinal oedema (94) Macular degeneration (51) Retinal vein occlusion (51) Diabetic retinopathy (35) Retinal oedema (17) Choroidal neovascularisation (11) Cystoid macular oedema (10) Diabetic eye disease (9)

Other Drugs Used for Macular oedema

AFLIBERCEPT (1,362) RANIBIZUMAB (1,185) BEVACIZUMAB (410) DEXAMETHASONE (354) FARICIMAB\FARICIMAB-SVOA (249) TRIAMCINOLONE ACETONIDE (102) FARICIMAB-SVOA (77) FLUOCINOLONE ACETONIDE (65) TRIAMCINOLONE (43) ADALIMUMAB (29)

Related Pages

LUCENTIS Full Profile All Macular oedema Drugs LUCENTIS Demographics LUCENTIS Timeline